Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
BeiGene and Agenus reach China rights agreement for two cancer antibodies
BeiGene announced that it had reached an agreement with Agenus for exclusive rights in China, including Hong Kong, Macao and Taiwan, to develop and commercialize Balstilimab and Zalifrelimab for specified indications and uses.